COX-2 has a critical role during incorporation of structural bone allografts

Annals of the New York Academy of Sciences

Volumn 1068, Issue 1, 2006, Pages 532-542

  O'Keefe, Regis J ^a,b   Tiyapatanaputi, Prarop ^a   Xie, Chao ^a   Li, Tian Fang ^a   Clark, Chris ^a   Zuscik, Micheal J ^a   Chen, Di ^a   Drissi, Hicham ^a   Schwarz, Edward ^a   Zhang, Xinping ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Allografts; COX 2; Cyclooxygenase; PGE2

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; KETOROLAC; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BONE ALLOGRAFT; BONE RADIOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; CORTICAL BONE; ENZYME ANALYSIS; ENZYME INHIBITION; FEMUR FRACTURE; FRACTURE HEALING; HEALING; INTRAMEDULLARY NAILING; MORPHOMETRICS; MOUSE; NONHUMAN; OSMOTIC MINIPUMP; OSSIFICATION; POSTOPERATIVE PERIOD; PROTEIN ANALYSIS; PROTEIN FUNCTION;

EID: 33744719718     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1346.012     Document Type: Conference Paper

References (44)

1. Vane, J.R. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New. Biol. 231 : 232 235.
2. Ferreira, S.H., S. Moncada & J.R. Vane. 1971. Indomethacin and aspirin abolish prostaglandin release from the spleen. Nat. New Biol. 231 : 237 239.
3. Smith, C.J. et al. 1998. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc. Natl. Acad. Sci. USA 95 : 13313 13318.
4. Seibert, K. et al. 1994. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. USA 91 : 12013 12017.
5. Nussmeier, N.A. et al. 2005. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N. Engl. J. Med. 352 : 1081 1091.
6. Bresalier, R.S. et al. 2005. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N. Engl. J. Med. 352 : 1092 1102.
7. Cheng, H.F. & R.C. Harris. 2005. Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors. Curr. Pharm. Des. 11 : 1795 1804.
8. Sudmann, E. & T. Hagen. 1976. Indomethacin-induced delayed fracture healing. Arch. Orthop. Unfallchir. 85 : 151 154.
9. Bo, J., E. Sudmann & P.F. Marton. 1976. Effect of indomethacin on fracture healing in rats. Acta Orthop. Scand. 47 : 588 599.
10. Tornkvist, H. & T.S. Lindholm. 1980. Effect of ibuprofen on mass and composition of fracture callus and bone. An experimental study on adult rat. Scand. J. Rheumatol. 9 : 167 171.
11. Sudmann, E. & G. Bang. 1979. Indomethacin-induced inhibition of haversian remodelling in rabbits. Acta Orthop. Scand. 50 : 621 627.
12. Ho, M.L., J.K. Chang & G.J. Wang. 1998. Effects of ketorolac on bone repair: a radiographic study in modeled demineralized bone matrix grafted rabbits. Pharmacology 57 : 148 159.
13. Zhang, X. et al. 2002. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J. Clin. Invest. 109 : 1405 1415.
14. Dimar, J.R.N. et al. 1996. The effects of nonsteroidal anti-inflammatory drugs on posterior spinal fusions in the rat. Spine 21 : 1870 1876.
15. Riew, K.D. et al. 2003. Time-dependent inhibitory effects of indomethacin on spinal fusion. J. Bone Joint Surg. Am. 85-A : 632 634.
16. Glassman, S.D. et al. 1998. The effect of postoperative nonsteroidal anti-inflammatory drug administration on spinal fusion. Spine 23 : 834 838.
17. Martin, G.J., JR.., S.D. Boden & L. Titus. 1999. Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion. Spine 24 : 2188 2193 discussion 2193-2194.
18. Giannoudis, P.V. et al. 2000. Nonunion of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs. J. Bone Joint Surg. 82B : 655 658.
19. Adolphson, P. et al. 1993. No effects of piroxicam on osteopenia and recovery after Colles' fracture. A randomized, double-blind, placebo-controlled, prospective trial. Arch. Orthop. Trauma Surg. 112 : 127 130.
20. Ritter, M.A. & J.M. Sieber. 1985. Prophylactic indomethacin for the prevention of heterotopic bone formation following total hip arthroplasty. Clin. Orthop. Relat. Res. 196 : 217 225.
21. Neal, B. et al. 2000. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty (Cochrane review). Cochrane Database Syst. Rev. 3 : CD001161.
22. Moed, B.R. et al. 1998. Heterotopic bone formation in male and female rabbits. J. South Orthop. Assoc. 7 : 86 89.
23. Moed, B.R. et al. 1994. Effect of two nonsteroidal antiinflammatory drugs on heterotopic bone formation in a rabbit model. J. Arthroplasty 9 : 81 87.
24. Simon, A.M., M.B. Manigrasso & J.P. O'Connor. 2002. Cyclo-oxygenase 2 function is essential for bone fracture healing. J. Bone Miner Res. 17 : 963 976.
25. Gerstenfeld, L.C. et al. 2003. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J. Orthop. Res. 21 : 670 675.
26. Bhandari, M. et al. 2003. Predictors of reoperation following operative management of fractures of the tibial shaft. J. Orthop. Trauma 17 : 353 361.
27. Ito, H. et al. 2005. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat. Med. 11 : 291 297.
28. Tiyapatanaputi, P. et al. 2004. A novel murine segmental femoral graft model. J. Orthop. Res. 22 : 1254 1260.
29. Burchardt, H. 1987. Biology of bone transplantation. Orthop. Clin. N. Am. 18 : 187 196.
30. Goldberg, V.M. & S. Stevenson. 1993. The biology of bone grafts. Semin. Arthroplasty 4 : 58 63.
31. Goodman, S. et al. 2002. COX-2 selective NSAID decreases bone ingrowth in vivo. J. Orthop. Res. 20 : 1164 1169.
32. Giordano, V. et al. 2003. Effect of tenoxicam on fracture healing in rat tibiae. Injury 34 : 85 94.
33. Endo, K. et al. 2002. Cyclooxygenase-2 inhibitor inhibits the fracture healing. J. Physiol. Anthropol. Appl. Human Sci. 21 : 235 238.
34. Thaller, J. et al. 2005. The effect of nonsteroidal anti-inflammatory agents on spinal fusion. Orthopedics 28 : 299 303 quiz 304-305.
35. Simon, A.M., C.T. Sabatino & J.P. O'Connor. 2001. Effects of cyclooxygenase-2 inhibitors on fracture healing. Trans. Orthop. Res. Soc. 26 : 205.
36. Brown, K.M. et al. 2004. Effect of COX-2-specific inhibition on fracture-healing in the rat femur. J. Bone Joint Surg. Am. 86A : 116 123.
37. Jorgensen, H.R., H. Svanholm & A. Host. 1988. Bone formation induced in an infant by systemic prostaglandin-E2 administration. Acta Orthop. Scand. 59 : 464 466.
38. Faye-Petersen, O.M. et al. 1996. Prostaglandin E1-induced hyperostosis: clinicopathologic correlations and possible pathogenetic mechanisms. Pediatr. Pathol. Lab. Med. 16 : 489 507.
39. Yoshida, K. et al. 2002. Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc. Natl. Acad. Sci. USA 99 : 4580 4585.
40. Li, M. et al. 2003. A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing. J. Bone Miner. Res. 18 : 2033 2042.
41. Paralkar, V.M. et al. 2003. An EP2 receptor-selective prostaglandin E2 agonist induces bone healing. Proc. Natl. Acad. Sci. USA 100 : 6736 6740.
42. Gerstenfeld, L.C. & T.A. Einhorn. 2004. COX inhibitors and their effects on bone healing. Expert Opin. Drug Saf. 3 : 131 136.
43. Giannoudis, P.V. et al. 2000. Nonunion of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs. J. Bone Joint Surg. Br. 82 : 655 658.
44. Reuben, S.S. & E.F. Ekman. 2005. The effect of cyclooxygenase-2 inhibition on analgesia and spinal fusion. J. Bone Joint Surg. Am. 87 : 536 542.